文献速递关节外科

双侧同期全膝关节置换采用传统器械相比技术辅助手术早期死亡率升高:一项基于国家登记系统的34,908例手术研究

Increased Early Mortality in Bilateral Simultaneous TKA Using Conventional Instrumentation Compared with Technology-Assisted Surgery: A Study of 34,908 Procedures from a National Registry.
PubMed 文献 · J Bone Joint Surg Am · 2021-09-21

基于国家登记系统34,908例双侧同期全膝关节置换(BSTKA)数据,比较传统器械与技术辅助器械的30天和90天死亡率。调整年龄、性别、手术年份等因素后,技术辅助BSTKA的30天死亡OR为0.26(95%CI 0.08-0.83),90天死亡OR为0.25(95%CI 0.09-0.72),提示技术辅助可显著降低早期死亡率。

要点

  • 技术辅助BSTKA的30天死亡风险显著低于传统器械(OR 0.26,95%CI 0.08-0.83)。
  • 90天死亡风险同样显著降低(OR 0.25,95%CI 0.09-0.72)。
  • 避免髓内杆相关脂肪栓塞可能是技术辅助降低死亡率的原因。

核心结论

  • 技术辅助BSTKA相比传统器械可显著降低早期死亡率,可能因减少脂肪栓塞,在人群层面具有临床重要性。

研究设计与样本

  • 基于大型国家登记系统2003至2019年34,908例BSTKA的回顾性比较研究,采用Firth逻辑回归调整年龄、性别、手术年份;2015至2019年手术额外调整ASA分级和BMI。

主要发现

  • 技术辅助BSTKA的30天死亡OR为0.26(95%CI 0.08-0.83,p=0.02),调整ASA和BMI后OR为0.26(95%CI 0.09-0.74,p=0.01)。
  • 90天死亡OR为0.25(95%CI 0.09-0.72,p=0.01),调整ASA和BMI后OR为0.26(95%CI 0.10-0.67,p=0.005)。
  • 研究期间技术辅助器械使用比例增加。

关键数值与推荐

  • 30天死亡率:技术辅助 vs 传统器械OR 0.26(95%CI 0.08-0.83;p=0.02),调整年龄、性别、手术年份。
  • 30天死亡率(额外调整ASA和BMI):OR 0.26(95%CI 0.09-0.74;p=0.01)。
  • 90天死亡率:OR 0.25(95%CI 0.09-0.72;p=0.01),调整年龄、性别、手术年份。
  • 90天死亡率(额外调整ASA和BMI):OR 0.26(95%CI 0.10-0.67;p=0.005)。

临床怎么用

  • 在双侧同期全膝关节置换中,优先考虑技术辅助器械以降低早期死亡风险。
  • 对于接受BSTKA的患者,选择避免髓内杆的技术辅助器械可能减少脂肪栓塞相关并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Controversy exists regarding the safety of bilateral simultaneous total knee arthroplasty (BSTKA). When conventional instrumentation is used, the increased fat emboli that result from the insertion of intramedullary rods may increase the risk of perioperative complications. We hypothesized that the use of technology-assisted instrumentation (avoiding intramedullary involvement) would be associated with a lower rate of early postoperative death compared with the use of conventional instrumentation. METHODS: We compared the 30 and 90-day rates of mortality following BSTKA performed with conventional versus technology-assisted instrumentation from 2003 to 2019, with use of data from a large national registry. Firth logistic regression analysis was utilized, adjusting for age, sex, and procedure year for all BSTKAs performed during the study period. For procedures performed from 2015 to 2019, odds ratios were additionally adjusted for American Society of Anesthesiologists physical status classification and body mass index. RESULTS: A total of 34,908 BSTKAs were identified. The proportion of cases utilizing technology-assisted instrumentation increased over the study period. The odds ratio of death within 30 days after technology-assisted BSTKA, adjusted for age, sex, and procedure year, was 0.26 (95% confidence interval [CI], 0.08 to 0.83; p = 0.02). The odds ratio, adjusted for age, sex, procedure year, American Society of Anesthesiologists classification, and body mass index, was 0.26 (95% CI, 0.09 to 0.74; p = 0.01). The corresponding odds ratios for 90-day mortality were 0.25 (95% CI, 0.09 to 0.72; p = 0.01) and 0.26 (95% CI, 0.10 to 0.67; p = 0.005), respectively. CONCLUSIONS: Technology-assisted BSTKA was associated with a significant reduction in early mortality compared with the use of conventional instrumentation. This difference may be explained by the reduced fat emboli associated with technology-assisted BSTKA and is likely to be clinically important on a population scale. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Kirwan DP, B Imis YP, Harris IA, et al. Increased Early Mortality in Bilateral Simultaneous TKA Using Conventional Instrumentation Compared with Technology-Assisted Surgery: A Study of 34,908 Procedures from a National Registry. J Bone Joint Surg Am. 2021. PMID: 34547000. doi:10.2106/JBJS.21.00029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。